細川 晃平 (ほそかわ こうへい) 講師 HOSOKAWA, Kohei
所属組織・役職等
附属病院 血液内科
講師
教育分野
所属研究室等
学歴
【取得学位】
博士(医学)
職歴
虎の門病院 内科 初期臨床研修医
NTT西日本金沢病院 内科 医員
アメリカ国立衛生研究所 客員研究員
生年月
所属学会
日本内科学会(専門医)
日本血液学会(専門医・指導医・評議員) 評議員(2019-2024)
日本造血細胞移植学会(認定医) 評議員(2024-2024)
日本輸血・細胞治療学会
欧州血液学会
米国血液学会
日本PNH研究会
血液疾患免疫療法学会
日本癌学会
学内委員会委員等
○放射線部運営委員会 委員(2023-2023)
○輸血部運営委員会 委員(2023-2023)
○薬事委員会 委員(2023-2023)
○材料部運営委員会 委員(2023-2023)
○ローカルスタディマネージャー 委員(2023-2023)
受賞学術賞
○第26回内科学会奨励賞(2013/04)
○日本血液学会総会 優秀ポスター賞(2013/10)
○Abstract achievement award アメリカ血液学会総会(2014/12)
○Abstract achievement award アメリカ血液学会総会(2015/12)
○Abstract achievement award アメリカ血液学会総会(2016/12)
○PNH Grant award from Aplastic anemia & MDS, International Foundation, Inc. 2015-2017
○第10回血液疾患免疫療法学会若手奨励賞(2018/09)
○日本血液学会奨励賞(2018/10)
○アメリカ血液学会 ASH Global Research Award(2019/07)
○第16回 金沢大学十全医学賞(2019/12)
○金沢市医師会金沢医学館記念医学賞(2021/11)
○2023 AAMDSIF Research Grant Award(2023/12)
専門分野
免疫学、血液内科学
専門分野キーワード
免疫学,血液内科学,造血幹細胞移植,造血障害,再生不良性貧血
研究課題
再生不良性貧血におけるクローン性造血
造血不全の免疫病態の解明
著書
- 再生不良性貧血の分子病態研究の進歩 EBM血液疾患の治療 2021-2022年版 2020/12 共著 細川晃平, 中尾眞二
- 再生不良性貧血におけるクローン性造血とゲノム異常の意義 月刊血液内科 80(3) 383‐389 2020/03 共著 細川晃平, 中尾眞二
- 造血不全症の病態解析研究と治療の進歩update 変異造血幹細胞による免疫性造血不全 月刊血液内科 79(2) 134‐139 2019/08 単著 細川晃平, 中尾眞二
- 小児科医に必要な免疫の知識 疾患における免疫系の関与―腫瘍・血液疾患 再生不良性貧血―肝炎後を含めて 小児内科 51(8) 1196‐1199 2019/08 単著 細川晃平, 中尾眞二
- 高精度フローサイトメトリー法の確立 PNH Frontier (6) 34‐37,1‐3 2019/07 単著 細川晃平, 中尾眞二
- 【臨床医学-ゲノム医療の深化と今後の展望2019(赤血球系疾患)-】再生不良性貧血 臨床血液 60(5) 417-422 2019/05 単著 細川 晃平, 中尾 眞二
- 貧血の読み方・捉え方 2‐2 実践編:貧血の検査データの読み方 Medical Technology 2018/11/01 単著
- 臨床研究紹介 PNH型血球割合の測定を目的とした2種類の高感度フローサイトメトリー法の比較 2018/06/01 単著
- Congenital and Acquired Bone Marrow Failure 2017/01/09 単著
- 再生不良性貧血におけるmiRNA解析の意義 細川晃平 血液フロンティア 2017年2月号 単著
- 全トランスクリプトームシークエンス法を用いた発作性夜間ヘモグロビン尿症関連新規経路の同定:PNH顆粒球におけるCXCR2発現量の増加 細川晃平 PNH Frontier 2016 No.3 単著
- PNH 型血球に関する最新の知見 細川晃平, 中尾眞二 内科 Volume 112, Issue 2, 223 - 228 (2013) 単著
- 膠原病に伴う骨髄異形成症候群・再生不良性貧血・無顆粒球症 細川晃平, 中尾眞二 血液フロンティア 2012年11月号(Vol.22 No.11) 単著
論文
- Takamatsu H, Yamada S, Tsuji N, Nakagawa N, Matsuura E, Kasada A, Sato K, Hosokawa K, Iwaki N, Arahata M, Tanaka H, Nakao S. Detection of antibodies against human leukocyte antigen class II in the sera of patients receiving intravenous immunoglobulin. Transplantation Direct. 2021; in press. 2021/06 査読有 原著論文
- Hagiwara G, Arahata M, Hosokawa K, Shimojima M, Nakao S. Congestive heart failure associated with POEMS syndrome that was adequately distinguished from cardiac amyloidosis: a case report and literature review. Ann Transl Med. 2021 2021/08 査読有 原著論文
- Tsuji N, Hosokawa K, Urushihara R, Tanabe M, Katagiri T, Ozawa T, Takamatsu H, Ishiyama K, Yamazaki H, Kishi H, Ogawa S, Nakao S. Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15. Leukemia. 2022; in press. 2022 査読有 原著論文
- Tanabe M, Hosokawa K, Nguyen MAT, Nakagawa N, Maruyama K, Tsuji N, Urushihara R, Espinoza L, Elbadry MI, Mohiuddin M, Katagiri T, Ono M, Fujiwara H, Chonabayashi K, Yoshida Y, Yamazaki H, Hirao A, Nakao S. The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-β. Leukemia. 2021; in press. 2021/11 査読有 原著論文
- Nakagawa N, Ishiyama K, Tanabe M, Yoroidaka T, Mizumaki H, Imi T, Zaimoku Y, Maruyama H, Hosokawa K, Yamazaki H, Nakao SThe effectiveness of immunosuppressive therapy in patients with aplastic anaemia secondary to chemoradiotherapy for cancers. Br J Haematol. 2021;195(5):770-780. 2021/12 査読有 原著論文
- Hosokawa K, Mizumaki H, Yoroidaka T, Maruyama H, Imi T, Tsuji N, Urushibara R, Tanabe M, Zaimoku Y, Nguyen MAT, Tran DC, Ishiyama K, Yamazaki H, Katagiri T, Hosomichi K, Tajima A, Azuma F, Ogawa S, Nakao S. HLA class I allele-lacking leukocytes predict rare clonal evolution to MDS/AML in patients with acquired aplastic anemia. Blood. 2021; in press. 2021/06 査読有 原著論文
- Yoroidaka T, Hosokawa K, Imi T, Mizumaki H, Katagiri T, Ishiyama K, Yamazaki H, Azuma F, Nanya Y, Ogawa S, Nakao S. Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemia. Leukemia. 2021, in press 2021/04 査読有 原著論文
- Hosokawa K, Ishiyama K, Ikemoto T, Sugimori C, Noji H, Shichishima T, Obara N, Chiba S, Ninomiya H, Nguyen MAT, Shirasugi Y, Nakamura Y, Ando K, Ueda Y, Yonemura Y, Kawaguchi T, Nishimura JI, Kanakura Y, Nakao S.The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failure. Ann Hematol. 2020 Oct 23. 2020/10/23 査読有 原著論文
- Hosokawa K, Aoki G, Ohata K, Takamatsu H, Nakagawa N, Imi T, Iwaki N, Ito K, Kawano M, Nakamura T, Takamori T, Ishiyama K, Kondo Y, Yamazaki H, Nakao S. Effectiveness of hyperbaric oxygen therapy for virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2021; in press. 2021/03 査読有 原著論文
- Hosokawa K, Yamazaki H, Tanabe M, Imi T, Sugimori N, Nakao S. High-dose romiplostim accelerates hematologic recovery in patients with aplastic anemia refractory to eltrombopag. Leukemia. 2020; in press. 2020/07 査読有 原著論文
- Mizumaki H, Hosomichi K, Hosokawa K, Yoroidaka T, Imi T, Zaimoku Y, Katagiri T, Nguyen MAT, Tran DC, Elbadry MIY, Chonabayashi K, Yoshida Y, Takamatsu H, Ozawa T, Azuma F, Kishi H, Fujii Y, Ogawa S, Tajima A, Nakao S. A frequent nonsense mutation in exon 1 across certain HLA-A and -B alleles in leukocytes of patients with acquired aplastic anemia. Haematologica. 2020; in press. 2020/06 査読有 原著論文
- Nguyen MAT*, Hosokawa K*, Yoroidaka T*, Maruyama H, Espinoza JL, Elbadry MI, Mohiuddin M, Tanabe M, Katagiri T, Nakagawa N, Chonabayashi K, Yoshida Y, Arima N, Kashiwase K, Saji H, Ogawa S, Nakao S. Resistance of KIR Ligand-Missing Leukocytes to NK Cells In Vivo in Patients with Acquired Aplastic Anemia. Immunohorizons. 2020; Jul 17; 4(7):430-441. 2020/07 査読有 原著論文
- Hosokawa K, Mizumaki H, Elbadry MI, Saito C, Espinoza JL, Thi Thanh Dao A, Katagiri T, Harashima A, Kikuchi A, Kanai A, Matsui H, Inaba T, Taniwaki M, Yamamoto Y, Nakao S. Clonal hematopoiesis by SLIT1-mutated hematopoietic stem cells due to a breakdown of the autocrine loop involving Slit1 in acquired aplastic anemia. Leukemia. 2019 Nov;33(11):2732-2766. 2019/06 査読有
- Hosokawa K, Nakao S, Acquired aplastic anemia.[Rinsho ketsueki] The Japanese journal of clinical hematology,60(5)417-422, 2019 2019/06 査読有
- Elbadry MI, Mizumaki H, Hosokawa K, Espinoza JL, Nakagawa N, Chonabayashi K, Yoshida Y, Katagiri T, Hosomichi K, Zaimoku Y, Imi T, Nguyen MAT, Fujii Y, Tajima A, Ogawa S, Takenaka K, Akashi K, Nakao S Escape hematopoiesis by HLA-B5401-lacking hematopoietic stem progenitor cells in men with acquired aplastic anemia.Haematologica, in press 2019/03/01 査読有
- Hosokawa K, Sugimori C, Ishiyama K, Takamatsu H, Noji H, Shichishima T, Obara N, Chiba S, Ninomiya H, Shirasugi Y, Nakamura Y, Ando K, Ueda Y, Yonemura Y, Kawaguchi T, Nishimura JI, Kanakura Y, Nakao S. Establishment of a flow cytometry assay for detecting paroxysmal nocturnal hemoglobinuria-type cells specific to patients with bone marrow failure. Ann Hematol. 2018 Jul 24 2018/07/24
- Banaszak LG, Giudice V, Zhao X, Wu Z, Gao S, Hosokawa K, Keyvanfar K, Townsley DM, Gutierrez-Rodrigues F, Fernandez Ibanez MDP, Kajigaya S, Young NS. Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing. Blood Cells Mol Dis. 2018 Mar;69:10-22 2018/01/04
- Hosokawa K, Kajigaya S, Keyvanfar K, Qiao Wangmin, Xie Yanling, Townsley DM, Feng X, Young NS.T Cell Transcriptomes from Paroxysmal Nocturnal Hemoglobinuria Patients Reveal Novel Signaling Pathways.J Immunol. 2017 In press
- Hosokawa K, Kajigaya S, Keyvanfar K, Qiao Wangmin, Xie Yanling, Biancotto A, Townsley DM, Feng X, Young NS. Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes. British J Haematol. 2017 Apr;177(1):136-141.
- Hosokawa K, Kajigaya S, Feng X, Desierto MJ2, Fernandez Ibanez MD, Rios O, Weinstein B, Scheinberg P, Townsley DM, Young NS. A plasma microRNA signature as a biomarker for acquired aplastic anemia. Haematologica 2017 Jan;102(1):69-78
- Maruyama H, Katagiri T, Kashiwase K, Shiina T, Sato-Otsubo A, Zaimoku Y, Maruyama K, Hosokawa K, Ishiyama K, Yamazaki H, Inoko H, Ogawa S, Nakao S. Clinical significance and origin of leukocytes that lack HLA-A allele expression in patients with acquired aplastic anemia. Exp Hematol 2016;44(10):931-939.
- Hosokawa K, Muranski P, Feng X, Townsley DM, Liu B, Knickelbein J, Keyvanfar K, Dumitriu B, Ito S, Kajigaya S, Taylor JG 6th, Kaplan MJ, Nussenblatt RB, Barrett AJ, O'Shea J, Young NS. Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic Anemia. J Immunol. 2016;196(4):1568-1578.
- Inaguma Y,Akatsuka Y, Hosokawa K, Maruyama H, Okamoto A, Katagiri T, Shiraishi K, Murayama Y, Tsuzuki-Iba S, Mizutani Y, Nishii C, Yamamoto N, Demachi-Okamura A, Kuzushima K, Ogawa S, Emi N,Nakao S.Induction of HLA-B*40:02-restricted T cells possessing cytotoxic and suppressive functions against hematopoietic progenitor cells from a patient with severe aplastic anemia. British J Haematol. 2016;172(1):131-134.
- Hosokawa K, Muranski P, Feng X, Keyvanfar K, Townsley DM, Dumitriu B, Chen J, Kajigaya S, Taylor JG, Hourigan CS, Barrett AJ, Young NS Identification of novel microRNA signatures linked to acquired aplastic anemia. Haematologica. 2015;100(12):1534-1545.
- Yoshizato T*, Dumitriu B*, Hosokawa K, Makishima H, Yoshida K, Townsley D, Sato-Otsubo A, Sato Y, Liu D, Suzuki H, Wu C, Shiraishi Y, Clemente M, Kataoka K, Shiozawa Y, Okuno Y, Chiba K, Tanaka H, Nagata Y, Katagiri T, Kon A, Sanada M, Scheinberg P, Miyano S, Maciejewski J, Nakao S, Young NS, Ogawa S. NEJM. 2015;373(1):35-47.
- Hosokawa K, Sugimori N, Katagiri T, Sasaki Y, Saito C, Seiki Y, Mochizuki K, Yamazaki H, Takami A, Nakao S. Increased glycosylphosphatidylinositol-anchored protein-deficient granulocytes define a benign subset of bone marrow failures in patients with trisomy 8. Eur J Haematol. 2015;95(3):230-8.
- Hosokawa K, Yamazaki H, Nakamura T, Yoroidaka T, Imi T, Shima Y, Ohata K, Takamatsu H, Kotani T, Kondo Y, Takami A, Nakao S. Successful hyperbaric oxygen therapy for refractory BK virus-associated hemorrhagic cystitis after cord blood transplantation. Transpl Infect Dis. 2014;16(5):843-6
- Hosokawa K, Takami A, Tsuji M, Araoka H, Ishiwata K, Takagi S, Yamamoto H, Asano-Mori Y, Matsuno N, Uchida N, Masuoka K, Wake A, Makino S, Yoneyama A, Nakao S, Taniguchi S. Relative incidences and outcomes of Clostridium difficile infection following transplantation of unrelated cord blood, unrelated bone marrow, and related peripheral blood in adult patients: a single institute study. Transpl Infect Dis. 2014;16(3):412-20.
- Mochizuki K, Kondo Y, Hosokawa K, Ohata K, Yamazaki H, Takami A, Sasaki M, Sato Y, Nakanuma Y, Nakao S. Adenovirus pneumonia presenting with nodular shadows on chest X-ray in two unrelated allogeneic bone marrow transplant recipients. Intern Med. 2014;53(5):499-503.
- Seiki Y, Sasaki Y, Hosokawa K, Saito C, Sugimori N, Yamazaki H, Takami A, Nakao S.. Increased plasma thrombopoietin levels in patients with myelodysplastic syndrome: a reliable marker for a benign subset of bone marrow failure. Haematologica. 2013;98(6):901-7.
- Katagiri T, Kawamoto H, Nakakuki T, Ishiyama K, Okada-Hatakeyama M, Ohtake S, Seiki Y, Hosokawa K, Nakao S. Individual hematopoietic stem cells in human bone marrow of patients with aplastic anemia or myelodysplastic syndrome stably give rise to limited cell lineages. Stem Cells. 2013;31(3):536-46.
- Takami A, Ohtake S, Morishita E, Terasaki Y, Fukushima T, Kurokawa T, Sugimori N, Matano S, Ohata K, Saito C, Yamaguchi M, Hosokawa K, Yamazaki H, Kondo Y, Nakao S.. Late response to low-dose imatinib in patients with chronic phase chronic myeloid leukemia. Int J Hematol. 2012;96(3):357-63.
- Nagai T, Suzuki T, Komatsu N, Hosokawa K, Nakao S, Ozawa K. Alteration of chromosome 13 abnormalities after therapeutic hematopoiesis recovery in myelodysplastic syndrome. Open Journal of Hematology 3-7. 2012.
- Hosokawa K, Katagiri T, Sugimori N, Ishiyama K, Sasaki Y, Seiki Y, Sato-Otsubo A, Sanada M, Ogawa S, Nakao S. Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO 'MDS-U' designation. Haematologica. 2012;97(12):1845-9.
- Hosokawa K, Yamazaki H, Nishitsuji M, Kobayashi S, Takami A, Fujimura M, Nakao S.. Pulmonary veno-occlusive disease following reduced-intensity allogeneic bone marrow transplantation for acute myeloid leukemia. Intern Med. 2012;51(2):195-8.
- Hosokawa K, Yamazaki H, Mochizuki K, Ohata K, Ishiyama K, Hayashi T, Kondo Y, Sugimori N, Okumura H, Takami A, Nakao S. Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B. Transpl Infect Dis. 2012;14(2):184-7.
- Ishiyama K, Katagiri T, Ohata K, Hosokawa K, Kondo Y, Yamazaki H, Takami A, Nakao S. Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation. Transpl Infect Dis. 2012;14(1):33-9.
- Katagiri T, Sato-Otsubo A, Kashiwase K, Morishima S, Sato Y, Mori Y, Kato M, Sanada M, Morishima Y, Hosokawa K, Sasaki Y, Ohtake S, Ogawa S, Nakao S. Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia. Blood. 2011 15;118(25):6601-9.
- Sano H, Hosokawa K, Kidoya H, Takakura N. Negative regulation of VEGF-induced vascular leakage by blockade of angiotensin II type 1 receptor. Arteriosclerosis, thrombosis, and vascular biology 26:2673-2680. 2006.
- Incidence of Acquired Pure Red Cell Aplasia: A Nationwide Epidemiologic Analysis With 2 Registry Databases in Japan. Blood advances 6巻 24号 6282頁 2022/05/06 研究論文(学術雑誌)
- Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia. Leukemia 36巻 9号 2317頁 2022/09 研究論文(学術雑誌)
- Hemolytic paroxysmal nocturnal hemoglobinuria: 20 years of medical progress Seminars in Hematology 2022 研究論文(学術雑誌)
- Hematopoietic stem progenitor cells with malignancy-related gene mutations in patients with acquired aplastic anemia are characterized by the increased expression of CXCR4. EJHaem 3巻 3号 669頁 2022/08 研究論文(学術雑誌)
- Minor GPI(-) granulocyte populations in aplastic anemia and healthy individuals derived from a few PIGA-mutated hematopoietic stem progenitor cells. Blood cancer journal 13巻 1号 165頁 2023/11/08
- [Clinical significance of detecting human leukocyte antigen class I allele-lacking leukocytes in aplastic anemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology 63巻 8号 899頁 2022 研究論文(学術雑誌)
- Hemophagocytic Lymphohistiocytosis With Elevated Cytokines Related to Macrophage Activation After Liver Transplantation for Autoimmune Hepatitis: A Case Report. Transplantation proceedings 2023/08/01 研究論文(学術雑誌)
- Clinical significance of the increased expression of the WT1 gene in peripheral blood of patients with acquired aplastic anemia. EJHaem 3巻 4号 1116頁 2022/11 研究論文(学術雑誌)
- A longitudinal analysis of paroxysmal nocturnal haemoglobinuria-type cells in patients with bone marrow failure: Results of a prospective multi-centre study in Japan. British journal of haematology 2023/08/31 研究論文(学術雑誌)
- [Immune pathophysiology of bone marrow failure]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64巻 9号 908頁 2023 研究論文(学術雑誌)
- Somatic mutations and clonal expansions in paroxysmal nocturnal hemoglobinuria. Seminars in hematology 59巻 3号 143頁 2022/07 研究論文(学術雑誌)
講演・口頭発表等
- 再生不良性貧血とクローン性造血(会議名:第45回シスメックス学術セミナー)(2023/06)
- 骨髄不全の免疫病態(会議名:第85回日本血液学会学術集会 )(2023/10)
- Immunosuppressive therapy(会議名:3rd REGIONAL SYMPOSIUM ON MYELODYSPLASTIC SYNDROMES)(2024/03)
- Recent advances in the pathogenesis and treatment of aplastic anemia(会議名:2023 Korean Society of Hematology International Conference & 64rd annual meeting)(2023/03)
- PNH clone expansion: our understanding in 2022 (2022/05)
- 再生不良性貧血におけるHLAクラスIアレル欠失血球検出の臨床的意義 (会議名:第83回日本血液学会学術集会 )(2021/10)
- 再生不良性貧血における分子病態の解明と診断・治療のバイオマーカーの開発.(会議名:令和3年 金沢大学十全医学会総会・学術集会 )(2021/06)
- High-dose romiplostim accelerates hematologic recovery in patients with aplastic anemia refractory to eltrombopag.(2020/06/12)
- Clonal hematopoiesis by HLA class I allele-lacking hematopoietic stem cells and concomitant aberrant stem cells is rarely associated with clonal evolution to secondary myelodysplastic syndrome and acute myeloid leukemia in patients with acquired aplastic anemia.(2020/12/05)
- Identification of T-Cell Receptors Specific to Antigens Presented By HLA-B4002 and B5401 in Acquired Aplastic Anemia(会議名:61th American Society of Hematology Annual Meeting & Exposition)(2019/12)
- Escape Hematopoiesis By HLA-B5401-Lacking Hematopoietic Stem Progenitor Cells in Male Patients with Acquired Aplastic Anemia(会議名:60th American Society of Hematology Annual Meeting & Exposition )(2018/12)
- B*54:01 欠失血球陽性再生不良性貧血は高率に男性に発症する(会議名:第10回血液疾患免疫療法学会学術集会)(2018/09/22)
- 免疫性造血不全における変異造血幹細胞によるエスケープ造血(会議名:第80回日本血液学会シンポジウム)(2018/10/14)
その他(報告書など)
芸術・フィールドワーク
特許
○HLAクラスIアレル欠失血球の検出方法
○HLAクラスIアレルにおける機能喪失型共通変異の検出方法
○PNH型白血球の検出方法 (特許番号:2012-122954)
共同研究希望テーマ
科研費
○基盤研究(C)(一般)「抗ネオ・セルフ抗体を利用した再生不良性貧血自己抗原の同定」(2024-2026) 代表者
○基盤研究(C)「HLA-DR15欠失血球陽性再生不良性貧血における免疫病態の解明」(2021-2023) 代表者
○若手研究「HLA-B*54:01陽性造血不全患者における免疫病態の解明」(2019-2020) 代表者
○若手研究(B)「再生不良性貧血を発症させるT細胞シグナルパスウェイの同定」(2017-2018) 代表者
競争的資金・寄付金等
○競争的資金(学外) (2022-2024) 研究 骨髄不全の分子基盤の解明と臨床応用 創発的研究支援事業
○競争的資金(学外) (2021-2023) 研究 HLA-DR15欠失血球陽性再生不良性貧血における免疫病態の解明 日本学術振興会:若手研究
○競争的資金(学外) (2017-2018) 研究 再生不良性貧血を発症させるT細胞シグナルパスウェイの同定 日本学術振興会: 若手研究(B)
○競争的資金(学外) (2019-2020) 研究 HLA-B*54:01陽性造血不全患者における免疫病態の解明 日本学術振興会:若手研究
○助成金 (2018-2018) 研究 公益財団法人 北國がん基金 研究活動部門
共同研究・受託研究実績
A-STEP採択課題
学域・学類担当授業科目
○内科診断学実習(2019)
○血液内科臨床実習BSL(2019)
大学院担当授業科目
○細胞移植学特論(2021)
○細胞移植学特論(2020)
○細胞移植学特論(2020)
○細胞移植学特論(2019)
○細胞移植学特論(2019)
○細胞移植学特論(2018)
他大学の客員教授
教育活動(FD)に関する研究
国際事業協力
留学生参加の社会活動
審議会等の参加
講演可能なテーマ
○血液がん
○再生不良性貧血
その他公的社会活動
○(20180920-) 北國新聞市民公開講座 「血液がんに挑む」